Regulus Therapeutics Inc (RGLS)
US$ 7.85-1.63%
Price Chart
Key Statistics
Market Cap
$ 564.95M
P/E Ratio
0.00
Revenue (TTM)
$ 5M
Volume
5.21M
52W High
$ 8.35
52W Low
$ 0.83
Dividend Yield
0.00%
Beta
0.37
Technicals
50-Day MA
6.774
200-Day MA
2.7944
52 Week High
8.345
52 Week Low
0.8301
About RGLS
Regulus Therapeutics Inc. engages in the development of drugs designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases.
Employees
34
Headquarters
San Diego, CA
CEO
Mr. Joseph P. Hagan M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg